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GenotypesAbstract Background: Systemic lupus erythematosus (SLE) is a common autoimmune disorder
which commonly results from the combined effects of a large number of genes. Variations in the
DNA sequence in the Interleukin-21 (IL-21) gene may lead to altered IL-21 production and/or
activity which can affect an individual’s susceptibility to SLE. IL-21 is a novel class I cytokine pro-
duced by activated CD4+ T cells, natural killer T cells and T helper (Th) cells. There is increasing
evidence that IL-21 contributes to the pathogenesis of SLE due to its biological activity.
Aim of the study: To investigate the association between single nucleotide polymorphism (SNP)
of IL-21 rs2221903 gene and serum IL-21 levels with SLE and to detect the possible association
between IL-21 serum levels and the pathogenesis of the disease.
Subjects and methods: This study was conducted on 30 SLE patients and 20 age and sex matched
healthy controls. Serum IL-21 levels were measured using enzyme-linked immunosorbent assay
(ELISA) technique and SNP of IL-21 rs2221903 gene was detected by genotyping assay, using real
time polymerase chain reaction (RT-PCR).
Results: Serum Il-21 levels were significantly higher in patients compared with controls
(p< 0.001). Patients with high activity index of SLE had significantly higher levels of serum
IL-21 (p value < 0.001). A statistically significant association was found between the T allele of
SNP rs2221903 and SLE, whereas; no association between SNP of IL-21 rs2221903 genotypes
and SLE or serum IL-21 levels could be detected.
Conclusion: IL-21 plays an important role in the immune-pathogenesis of SLE and could be used
as a possible target for novel immunotherapy. The T allele of SNP rs2221903 suggests that the IL-21
gene may contribute to an inherited predisposition to SLE.
 2016 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).vels with
2 Y.M. Ahmed et al.1. Introduction
Systemic lupus erythematosus (SLE) is a prototypic, systemic,
autoimmune disease. It is characterized by a diverse array of
autoantibody production, complement activation and
immune-complex deposition, which causes tissue and organ
damage. The etiology and pathogenetic mechanisms of SLE
have not been clearly elucidated [1]. Epidemiological studies
suggest strong contribution of genetic factors in the develop-
ment of SLE [2]. SLE commonly results from the combined
effects of a large number of genes. Each allele contributes only
mildly and the accumulation of several genes is presumed nec-
essary to significantly increase the risk of SLE. The combina-
tions of risk alleles that lead to predisposition and the
mechanisms through which they contribute to autoimmunity
are poorly understood. In fact, most single nucleotide poly-
morphisms (SNPs) associated with SLE fall within non coding
DNA regions (introns) and represent markers of co-segregated
alleles. Most of them are associated with genes presumed to be
involved in the immune response [3].
In humans, the Interleukin-21 (IL-21) gene is located on
chromosome 4q26-q27, which consists of 5 exons spanning
approximately 8.44 kb of genomic DNA [4]. Variations in
the DNA sequence in the IL-21 gene may lead to altered IL-
21 production and/or activity which can affect an individual’s
susceptibility to SLE. Several polymorphisms in the IL-21 gene
have been identified [5–9]. Many of them may be associated
with different autoimmune and inflammatory diseases, such
as Graves’ disease, rheumatoid arthritis and inflammatory
bowel disease suggesting a common genetic background for
these diseases [10–13,5].
IL-21 is a novel four helix bundle class I cytokine produced
endogenously by activated CD4+ T cells, natural killer T cells
and T helper (Th) cells [14–16]. IL-21 is an important factor
for the activation, proliferation, differentiation, antibody pro-
duction, or death of murine B cells, with the outcome being
dependent on the context of co-stimulation [17]. Also, IL-21
is an important regulator of T cell expansion, differentiation
and effector function and can act in concert with other type
I cytokines to further enhance the growth of CD4+ T cells.
It also regulates human CD8+ T cells activation, survival,
and memory formation. IL-21 is also important for the expan-
sion and maintenance of the Th17 lineage that produces an
array of pro-inflammatory molecules including IL-1, IL-6,
IL-17, IL-21, IL-22, and tumor necrosis factor-a (TNFa) [18].
Recently, there is increasing evidence that IL-21 contributes
to the pathogenesis of chronic inflammatory and autoimmune
diseases due to its biological activity. Animal studies of SLE
have indicated that IL-21 is important in the pathogenesis of
murine lupus. SLE patients have higher serum levels of IL-
21 than healthy controls. Moreover, association of IL-21 and
IL-21R polymorphisms with susceptibility to SLE has been
reported [5,19].
2. Aim of the work
The present study aimed to find if there is an association
between SNP of IL-21 rs2221903 gene and SLE and whether
it can serve as a novel genetic marker of susceptibility to the
disease, and to detect the possible association of IL-21 serum
levels and the pathogenesis of the disease.Please cite this article in press as: Ahmed YM et al., The association of single nucle
systemic lupus erythematosus, Egypt J Med Hum Genet (2016), http://dx.doi.org/103. Subjects and methods
3.1. Patients and controls
This observational cross sectional study was conducted on
thirty patients (27 females and 3 males) diagnosed with sys-
temic lupus erythematosus (Group 1) based on Systemic Lupus
International Collaborating Clinics (SLICC) classification cri-
teria for SLE [20], and twenty apparently healthy subjects
matched for age and sex (Group 2) with no history of autoim-
mune diseases (17 females and 3 males). Patients were recruited
from Rheumatology Department, Ain Shams University
Hospitals between June and November 2014. Patients and con-
trol individuals participated in this study after informed con-
sent was obtained. The work has been carried out after
approval of Ain Shams University Ethics Committee and in
accordance with The Code of Ethics of the World Medical
Association (Declaration of Helsinki) for experiments in
humans.
All the patients were subjected to full history taking, thor-
ough clinical examination, and laboratory investigations which
included complete blood count (CBC), erythrocyte sedimenta-
tion rate (ESR), antinuclear antibody (ANA), and anti-double
stranded DNA. An assessment of disease activity in patients
with SLE was done by Systemic Lupus Erythematosus Disease
Activity Index (SLEDAI); twenty-four features that were
attributed to lupus were listed, with a weighted score given
to any present feature. The more serious manifestations (such
as renal, neurologic, and vasculitis) were weighted more than
others (such as cutaneous manifestations) [21].
3.2. Blood sampling
Five milliliters of venous blood were taken from all study par-
ticipants under complete aseptic conditions. Each sample was
divided into 2 tubes. Three milliliters were added to EDTA
containing sterile tubes and stored at 80 C till real time poly-
merase chain reaction (RT-PCR) was done. Two milliliters
were added to sterile empty tubes and were allowed to clot
for 30 min then centrifuged for 15 min at 1000g. Serum
was then aliquoted and stored at 20 C until used in
enzyme-linked immunosorbent assay (ELISA).
3.3. Serum IL-21 determination
The serum levels of IL-21 were measured using a commercially
available quantitative sandwich ELISA technique (IBL inter-
national GMBH, Hamburg, Germany) following the manufac-
turer’s instructions. Optical densities at 450 nm were read
within 10 min of adding stop solution. The detection limit of
the assay was 20 pg/mL.
3.4. Genotyping for IL-21 gene
We used TaqMan single nucleotide polymorphism (SNP)
genotyping assay, using RT-PCR.
3.4.1. DNA extraction
It was done using PureLink Genomic DNA Mini Kit (Invit-
rogen, USA), for purification of DNA from blood accordingotide polymorphism of interleukin-21 gene and serum interleukin-21 levels with
.1016/j.ejmhg.2016.04.006
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and 20 ll RNase A were added to 200 ll blood sample in ster-
ile microcentrifuge tube, then incubated at room temperature
for 2 min. 200 ll buffer was added and incubated for 10 min,
followed by 200 ll ethanol. 640 ll lysate was added to spin col-
umn and centrifuged at 10,000g for 1 min at room tempera-
ture. Washing was done in 2 steps using 500 ll washing buffer,
final elution was then done in 200 ll elution buffer by centrifu-
gation at maximum speed for 1 minute at room temperature.
3.4.2. PCR amplification
PCR amplification was carried out using a thermal cycler
(Applied Biosystems, USA) with SNP Genotyping Assay. The
assay contained sequence-specific forward and reverse primers
to amplify the polymorphic sequence and two TaqMan
minor grove binding (MGB) probes (One probe labeled with
VIC dye which detected the C allele sequence and one probe
labeled with FAMTM dye which detected the T allele sequence).
Context sequence [VIC/FAM] ACAGACAATGGGGTTTTG
TTTTCTT[C/T] TGTTCTGCAAGCAG AGAGCTGTGT.
PCR was performed in 25 ll of reaction mixture containing
20 ng of each DNA sample, TaqMan Universal PCR Master
Mix (Applied Biosystems, USA) and SNP genotype assay
(Applied Biosystems, USA). PCR was done as follows; enzyme
activation at 95 C, followed by 40 cycles of denaturation at
95 C for 15 s and annealing/extension at 60 C for 1 min.
3.4.3. Post-PCR plate read and analysis (Allelic Discrimination
Plate Reading and Analysis)
After PCR amplification, an endpoint plate read was per-
formed using an Applied Biosystems RT-PCR System. The
Sequence Detection System (SDS) Software used the fluores-
cence measurements made during the plate read to plot fluores-
cence (Rn) values based on the signals from each well. The
plotted fluorescence signals indicated which alleles were in each
sample. The blue fluorescent FAM dye indicated the T allele,
while the green fluorescent VIC dye indicated the C allele.
ROX is a reference dye with red fluorescence. Identification
of genotypes was based on the relative fluorescence from each
well on a 48-well plate (Figs. 1–3).
Fig. 1 is an example of a heterozygous C/T genotype. The
multi-component plot shows both green and blue curves which
corresponds to the C and T alleles respectively.
Fig. 2a is an example of a homozygous T/T genotype. The
multi-component plot shows one blue curve which corre-
sponds to T allele. While Fig. 2b is an example of a homozy-
gous C/C genotype, the multi-component plot shows one
green curve which corresponds to C allele.
3.5. Statistical analysis
Continuous data e.g. age were presented as range, mean and
standard deviation. Qualitative data e.g. sex were presented
as numbers and percentages. Student’s t test was used to com-
pare continuous data between two independent groups and a
One Way ANOVA test was used to compare continuous data
between more than two groups. Chi square test was used to
compare qualitative data between different groups. The signif-
icance level was set at P 6 0.05. Statistical analysis was per-
formed with IBM SPSS Statistics Version 20 for Windows.Please cite this article in press as: Ahmed YM et al., The association of single nucleo
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4.1. Clinical characteristics of the study participants
The age of Group 1 (patient group) ranged from 21 to 42 years
with a mean of 32.7 ± 5.58 years, regarding sex, 27 (90%)
patients were females and 3 (10%) patients were males. The
age of Group 2 (control group) ranged from 23 to 41 years
with a mean of 32.65 ± 5.70 years, 17 (85%) were females
and 3 (15%) were males. There was no statistically significant
difference between the 2 groups (Table 1). Clinical manifesta-
tions in patients are presented in Fig. 3.
4.2. IL-21 serum levels
The serum IL-21 levels were significantly higher in the patient
group (group 1) than those in the control group (group 2)
(mean = 310.35 ± 129.61) vs (mean 223.67 ± 30.53) (Table 2).
Patients with high activity index of SLE had significantly higher
levels of serum IL-21 than those with lower index score
(p value < 0.001) (Fig. 4). A statistically significant association
between nephritis and serum IL-21 levels (p value = 0.01) was
detected, while no association was found between serum IL-21
levels and other clinical findings Table 3.
4.3. The genotype and allele frequencies of IL-21 gene
4.3.1. Genotype assessment
The homozygous T/T was the predominant genotype in the
patient group (73%); whereas, both homozygous T/T and
heterozygous C/T types were equally represented in the control
group (45% each). No statistical significant difference was
detected between the 2 groups regarding genotype distribution
(Table 4). No correlation was found between SNP in IL-21
rs2221903 and serum IL-21 levels p value = 0.15 (Fig. 5).
4.3.2. Allele assessment
The frequency of (T) allele was much higher than (C) allele in
both SLE patients and controls. The frequency of T allele was
(85%) n= 51 in SLE patients while the C allele was (15%)
n= 9. The frequency of the T allele was significantly higher
in the patient group than in the control group (p= 0.038)
(Fig. 6).
5. Discussion
To our knowledge, this is the first study to determine whether
the IL-21 gene polymorphism and its soluble levels are associ-
ated with SLE in Egypt, other studies were done on other eth-
nic populations such as Europeans, African-Americans, and
Asians.
In this study, serum levels of IL-21 were significantly ele-
vated in SLE patients in comparison to healthy controls. The
mechanisms leading to elevated IL-21 are unknown but this
is believed to lead to increased production of auto-antibodies
[22,23].
Our results come in agreement with the results obtained by
other studies who found that the plasma soluble IL-21 levels
were significantly higher in SLE patients compared to controls
[9,24,25]. In addition, Wang et al. found that concentrations oftide polymorphism of interleukin-21 gene and serum interleukin-21 levels with
.1016/j.ejmhg.2016.04.006
Figure 2 Plotted fluorescence signals indicating homozygous T/T genotype and homozygous C/C genotype in 2 different samples.
Figure 1 Plotted fluorescence signals indicating both C and T alleles in a heterozygous C/T genotype.
4 Y.M. Ahmed et al.serum IL-21 were gradually reduced, after initiation of treat-
ment particularly at week 12. They suggested that increased
levels of serum IL-21 may be associated with the early process80%
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Figure 3 Clinical manifestations of SLE patients.
Please cite this article in press as: Ahmed YM et al., The association of single nucle
systemic lupus erythematosus, Egypt J Med Hum Genet (2016), http://dx.doi.org/10of SLE in Chinese patients [24]. Lee et al., also found that the
mRNA expression of IL-21 was significantly higher in PBMCs
and CD4+ T cells from SLE patients than in those from
healthy control [25].
In contrast Pan et al. found that IL-21 levels were signifi-
cantly decreased in the serum of patients with SLE compared
with controls [26]. Nakou et al. found no difference in serum
IL-21 levels between patients and controls. However, they
found a 4-fold increase in mRNA and significantly higher
intracellular levels of IL-21 in T-cells in active SLE patients
compared to inactive SLE patients and healthy individuals
[22]. The discrepancy with our results could be explained by
several potential explanations; first, the treatment might influ-
ence the expression level of IL-21, second, it was also possible
that there was retention of IL-21 within the tissues or organs in
SLE patients, resulting in reduction in peripheral blood levels,
so, further detection of IL-21 expression level in tissues or
organs, such as renal tissue is essential [26].otide polymorphism of interleukin-21 gene and serum interleukin-21 levels with
.1016/j.ejmhg.2016.04.006
Figure 4 Relation between levels of serum IL-21 and activity index of SLE.
Table 1 Demographic data of the studied groups.
Patients (N= 30) Control subjects (N= 20) Student t test P value
Mean ± SD Range Mean ± SD Range
Age (years) 32.7 ± 5.58 21–42 32.6 ± 5.70 23–41 0.05 0.96 NS
No (%) No (%) Chi Square test P value
Sex Female 27 (90.0%) 17 (85.0%) 0.28 (Fisher Exact) 0.67 NS
Male 3 (10.0%) 3 (15.0%)
Table 2 IL-21 serum levels in SLE patients and controls.
IL-21 serum levels Student t test p Value
Mean ± SD Mini (pg/ml) Max(pg/ml)
Patients (N= 30) 310.35 ± 129.61 220 790.3 3.52 0.001*
Control subjects (N= 20) 223.67 ± 30.53 160.6 281.2
* p Value 0.001 highly significant.
Table 3 Correlation between IL-21 serum levels and clinical findings of the patients.
IL-21 serum levels Student t test P value
Mean ± SD
Muco-cutaneous ve 268.77 ± 8.15 1.36 0.19
+ve 334.42 ± 153.35
Musculo-cutaneous ve 297.51 ± 104.27 0.57 0.57
+ve 325.02 ± 156.51
Neurological defects ve 257.7 ± 31.45 3.78 0.09
+ve 429 ± 237.8
Nephritis ve 253.52 ± 27.79 3.05 0.01*
+ve 424.01 ± 175.97
* p Value 0.01 significant.
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Table 4 Genotype distribution of SNP in IL-21 rs2221903 among patient group and control group.
Groups Total (N= 50) Chi Square test P value
Patients (N= 30) Control subjects (N= 20)
No (%) No (%) No (%)
SNP T/T 22 (73.3) 9 (45) 31 (62) 4.20 (Fisher Exact) 0.12
C/T 7 (23.3) 9 (45) 16 (32)
C/C 1 (3.3) 2 (10) 3 (6)
6 Y.M. Ahmed et al.In the current study, statistically significant association was
found between serum levels of IL-21 and nephritis. On the
other hand, no statistically significant association was found
between serum IL-21 levels and other clinical findings.
MRL-Faslpr mice with blockade of IL-21 by treating with anti
IL-21R/Fc showed significantly reduced proteinuria, circulat-
ing autoantibodies and levels of glomerular IgG deposits in
the kidney with no thickening in glomerular basement mem-
branes by histological test [27]. However, Pan et al. found noFigure 5 Correlation between SNP in IL
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Figure 6 Allelic distribution of SNP in IL-21 rs222
Please cite this article in press as: Ahmed YM et al., The association of single nucle
systemic lupus erythematosus, Egypt J Med Hum Genet (2016), http://dx.doi.org/10significant difference regarding serum IL-21 level between
SLE patients with nephritis and those without nephritis [26].
In our study, we found that SLE patients with a higher
activity index score had significantly higher levels of serum
IL-21 than those with a lower index score; these results verify
the active role of IL-21 in immune-pathogenesis of SLE and its
contribution to severity of clinical findings. In concordance to
our results Nakou et al. and Wang et al. found that the levels
of serum IL-21 were correlated positively with the values of-21 rs2221903 and serum IL-21 levels.
Control subjects
67.50%
32.50%
stribuon 
C allele
1903 in the studied groups. *One Way ANOVA.
otide polymorphism of interleukin-21 gene and serum interleukin-21 levels with
.1016/j.ejmhg.2016.04.006
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of memory and plasma cells [22,24].
Approximately 90% of DNA polymorphisms are SNPs due
to single base substitutions. Some have effects on regulation of
gene expression or on the function of the coded protein. These
functional polymorphisms, despite being of low penetrance,
could contribute to the differences between individuals in sus-
ceptibility to and severity of disease [28,29].
In this study, a statistically significant association was
found between the T allele of SNP rs2221903 and SLE. The
T allele was found to be the major allele in both patients
and controls (85% vs 67.5%), while the C allele was 15%
and 32.5% in patients and controls respectively. The frequency
of T allele was significantly elevated in SLE patients in com-
parison to controls.
These results are in accordance with those reported by Ding
et al.; the T allele frequency was significantly higher in SLE
patients compared to controls (89.4% vs 86.8%), while the C
allele frequency was 10.6% in SLE patients and 13.2% in
the controls. They concluded that the T allele was a risk factor
for SLE [8]. Swalha et al. genotyped three SNPs located within
the IL-21 gene in several ethnic groups. The T allele of SNP
rs2221903 was found to be the major allele in both patients
and controls, but they found that the T allele frequency was
significantly lower in SLE patients compared to controls of
both European American and African-American groups. In
African American participants, they found that the T allele
frequencies were 90.6% and 94% in the patients and control
groups respectively [5].
Another study was done in USA by Hughes et al. in 2 large
independent lupus sample sets. In participants of European
descent, the T allele SNP rs2221903 was found to be the major
allele in both patients and controls, and its frequency was sig-
nificantly lower in SLE patients compared to controls. The T
allele frequency was 68% in patient group, while in the control
group the T allele frequency was 70% [30]. Lan et al. failed to
detect significant association between any of the two alleles and
the disease [9]. Qi et al. reported significant differences in the
SNP of IL-21 rs2221903 allelic distribution between SLE
patients and healthy controls in patients with European ances-
try; however the C allele was the risk allele [4]. The discrepancy
with their results may be due to genetic variation between dif-
ferent ethnic groups, and small sample size in this study.
In this study we failed to find an association between SNP
of IL-21 rs2221903 genotypes and SLE, In agreement, Ding
et al. and Lan et al. reported no significant association between
the SNP of IL-21 rs2221903 genotypes and SLE [8,9]. How-
ever, Swalha et al. reported that a significant association was
found between the SNP of IL-21 rs2221903 genotypes and
SLE in European-American group, while no association was
found in the African-American group [5]. Qi et al. observed
that no significant association was found between different
genotypes and SLE in African-American or Asian popula-
tions. On the other hand, SNP of IL-21 rs2221903 might be
associated with SLE in Caucasian population [4]. The results
from these studies were inconsistent and IL-21 rs2221903 gene
polymorphisms were distinct in different population, this
could be attributed to ethnic variation.
In this study we failed to find a statistically significant asso-
ciation between the SNP of IL-21 rs2221903 and serum IL-21
levels. Similar result was reported by Lan et al. [9]. The IL-21
rs2221903 SNP is located in the second intron of IL-21 gene.Please cite this article in press as: Ahmed YM et al., The association of single nucleo
systemic lupus erythematosus, Egypt J Med Hum Genet (2016), http://dx.doi.org/10Intronic SNPs may be associated with functional consequences
i.e. a variant that influences the translation of m RNA. How-
ever, the significance of non-coding SNPs is evolving [31].
Therefore, larger sample size may be needed to prove such
an association.
6. Conclusion
IL-21 plays an important role in the immune-pathogenesis of
SLE, this was proven by its elevated serum levels in patients
and its association with activity score index. Thus, IL-21
may represent a novel target for the treatment of SLE and
could be used as a marker for disease activity and treatment
follow up. The T allele of SNP rs2221903 suggests that the
IL-21 gene may contribute to an inherited predisposition to
SLE although additional studies with larger sample sizes will
be necessary to confirm our findings.
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